Home » Posts tagged with » Canada
COVID-19 treatment : Cyclica, Institute of Materia Medica partner on drug repurposing for coronavirus

COVID-19 treatment : Cyclica, Institute of Materia Medica partner on drug repurposing for coronavirus

COVID-19 treatment : The Institute of Materia Medica, Chinese Academy of Medical Sciences has entered into a collaboration with Canadian biotech company Cyclica for discovering antiviral drug candidates for COVID-19 (novel coronavirus) and for exploring opportunities for designing multi-targeted antiviral compounds. According to the partners, new drug development efforts to tackle the prevailing pandemic of […]

Antibe Therapeutics completes patient enrollment in OA knee pain trial for ATB-346

Antibe Therapeutics, a Canadian pharma company has completed enrollment of patients in a phase 2B dose-ranging, efficacy clinical trial of its lead drug candidate ATB-346 for its use in reducing osteoarthritis (OA) pain. The mid-stage clinical study will assess the effectiveness of ATB-346 in the reduction of OA knee pain in comparison to placebo in […]

Continue reading …
ResMed launches tube-up full face CPAP mask AirFit F30i

ResMed, a California-based medical equipment company, has launched AirFit F30i, a tube-up full face continuous positive airway pressure (CPAP) mask for patients with obstructive sleep apnea. With the launch, the company has completed its full face mask portfolio on the market. Full face CPAP users have options to choose from the type of connection either […]

Continue reading …
PCI acquires Canadian pharma packaging company Bellwyck Pharma Services

PCI Pharma Services, a pharma supply chain solutions provider, has acquired Canada-based pharma packaging company Bellwyck Pharma Services for an undisclosed price. Bellwyck Pharma Services has been serving the clinical trial and commercial drug markets with primary and secondary packaging and labeling for 25 years. Its acquisition will give four GMP-compliant facilities for PCI Pharma […]

Continue reading …
Levo gets FDA fast track status for LV-101 in Prader-Willi syndrome

US biotech company Levo Therapeutics has been granted fast track designation for LV-101 (intranasal carbetocin) from the US Food and Drug Administration (FDA) for the treatment of Prader-Willi syndrome (PWS). According to the US National Library of Medicine, Prader-Willi syndrome is a complex genetic condition that impacts several parts of the body. In infancy, Prader-Willi […]

Continue reading …
Amplia Pharmatek acquired by NuChem Therapeutics

NuChem Therapeutics has wrapped up the acquisition of Amplia Pharmatek, a Quebec-based drug discovery and development contract research organization (CRO) with a focus on biology. Based in Montreal, NuChem Therapeutics too is a drug discovery and development CRO. The company specializes in synthetic and medicinal chemistry services. Amplia Pharmatek, on the other hand, is a […]

Continue reading …
Mindmed acquires 18-MC opioid addiction drug candidate from Savant HWP

Mindmed acquisition of 18-MC : Canada-based Mind Medicine (Mindmed) has acquired opioid addiction drug candidate 18-MC from Savant HWP for an undisclosed price, as per the latest pharma acquisition news. 18-MC, which is derived from ibogaine – a natural psychedelic substance, is being developed for addressing the opioid crisis and other types of addiction. The […]

Continue reading …
Cutera truSculpt iD body sculpting treatment gets expanded approval in Canada

Cutera said that Health Canada has expanded approval for its truSculpt iD body sculpting treatment to cover its use for the reduction of circumference of the abdomen and non-invasive lipolysis, which is the permanent removal of fat cells from the body. According to American Society for Aesthetic Plastic Surgery and Medical Insight (MII), noninvasive body sculpting […]

Continue reading …
Mallinckrodt to sell Canadian CDMO BioVectra to H.I.G. Capital for $250m

Mallinckrodt sale of BioVectra to H.I.G. Capital : Irish biopharma company Mallinckrodt has agreed to divest its wholly-owned subsidiary BioVectra, a Canadian CDMO (contract development and manufacturing organization) to an affiliate of H.I.G. Capital for nearly US$250 million, as per the latest pharma acquisition news. The transaction amount to be paid by H.I.G. Capital, which is […]

Continue reading …
Khiron begins construction on medical cannabis production plant in Uruguay

Khiron Life Sciences, a Canadian cannabis producer, has begun the construction on a new medical cannabis production plant in Uruguay, thereby expanding multi-jurisdiction and export capacity. The new cannabis cultivation and processing facility is located in Juan Lacaze. The medical cannabis production plant with a production capacity of 17 tons per year will increase Khiron […]

Continue reading …
Page 1 of 212